U.S. Gold Corp. (LON:0LHW)

Theseus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Cash & Equivalents	8.17	5.57	7.82	9.11	13.65
Cash & Short-Term Investments	8.17	5.57	7.82	9.11	13.65
Cash Growth	46.54%	-28.74%	-14.14%	-33.23%	396.20%
Prepaid Expenses	0.73	0.95	0.61	0.79	0.43
Total Current Assets	8.9	6.52	8.43	9.9	14.08
Property, Plant & Equipment	14.84	14.9	14.89	16.77	16.53
Other Long-Term Assets	1.13	1.16	0.86	0.83	0.72
Total Assets	24.87	22.58	24.18	27.5	31.32
Accounts Payable	0.44	0.35	0.35	1.08	0.62
Accrued Expenses	0.2	-	-	-	-
Current Portion of Leases	0.03	0.06	0.03	0.06	-
Other Current Liabilities	0.21	0.04	-	-	-
Total Current Liabilities	0.88	0.45	0.38	1.14	0.62
Long-Term Leases	-	0.01	-	0.01	-
Long-Term Deferred Tax Liabilities	0.43	0.43	0.43	0.43	-
Other Long-Term Liabilities	11.97	4.22	4.52	2.7	0.2
Total Liabilities	13.28	5.12	5.33	4.28	0.82
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	104.98	90.3	84.8	81.56	74.47
Retained Earnings	-93.41	-72.85	-65.95	-58.34	-43.98
Total Common Equity	11.59	17.46	18.86	23.23	30.5
Shareholders' Equity	11.59	17.46	18.86	23.23	30.5
Total Liabilities & Equity	24.87	22.58	24.18	27.5	31.32
Total Debt	0.03	0.07	0.03	0.06	-
Net Cash (Debt)	8.13	5.5	7.79	9.05	13.65
Net Cash Growth	47.79%	-29.35%	-13.89%	-33.70%	396.20%
Net Cash Per Share	0.71	0.59	0.93	1.25	2.90
Filing Date Shares Outstanding	14.03	10.73	9.3	8.35	7.09
Total Common Shares Outstanding	12.69	10.73	9.3	8.35	7.07
Working Capital	8.02	6.07	8.05	8.76	13.46
Book Value Per Share	0.91	1.63	2.03	2.78	4.32
Tangible Book Value	11.59	17.46	18.86	23.23	30.5
Tangible Book Value Per Share	0.91	1.63	2.03	2.78	4.32
Land	0.35	0.35	0.35	0.18	-
Machinery	0.05	0.04	0.05	0.05	0.04

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.